Corrigendum to the Annual Report for FY 2025-26

Archit Organosys Limited 903, 9th Floor, Venus Benecia, Nr. Pakwan Restaurant, Bodakdev, S. G. Highway, Ahmedabad-380054, Gujarat, India. CIN: L24110G.11993PLC019941 Date: 24th September, 2026 BSE Limited Phiroze Jeejeebhoy Towers, Dalal Street, Mumbai – 400 001 BSE Scrip Code: 524640 ISIN: INE078I01011 Sub: Corrigendum to the Annual Report for FY 2025-26 Ref: Regulation 34 of SEBI (LODR) Regulations, 2015 Dear Sir/Madam, This is with reference to the Annual Report of Archit Organosys Limited (“Company”) for the Financial Year 2025-26, submitted to the Stock Exchanges on September 7, 2026, pursuant to Regulation 34 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The Company hereby informs that Agenda Item Nos. 8, 9 and 10, along with the respective Explanatory Statements thereto, forming part of the Notice of the AGM, have been withdrawn by the Management. Accordingly, the Company is issuing this Corrigendum after removing the said Agenda Items from the Notice of the AGM. Accordingly, the following Agenda Items shall stand withdrawn from the Notice of the AGM: Item Number 8 - Increase in Authorized Share Capital and consequent alteration of MOA of the company. Item Number 9 - Approval for the Acquisition of up to 1,36,24,172 (One Crore Thirty-Six Lakh Twenty-Four Thousand One Hundred Seventy-Two) equity shares i.e. 67.44% of the Equity Share Capital of M/s. Archit Life Science Limited form its selling shareholders as a Material Related Party Transaction. Item Number 10 - To Offer, Issue and Allot Equity Shares (Other than Cash) on a Preferential Basis. Consequently, the respective Explanatory Statements relating to Item Nos. 8, 9 and 10 shall also stand withdrawn and shall not form part of the business to be transacted at the AGM. This Corrigendum shall form an integral part of the Annual Report of the Company for FY 2025-26 submitted to the Stock Exchanges on September 7, 2026, and circulated to the Members of the Company. The Corrigendum/Addendum has also been dispatched to the concerned shareholders on September 24, 2026. Except for the above amendments, all other contents of the Annual Report for FY 2025-26 and the Notice of the AGM shall remain unchanged. The Corrigendum/Addendum is also available on the Company’s website at www.architorg.com, Stock exchange website at www.bseindia.com and on the NSDL e-Voting website at www.evoting.nsdl.com. You are requested to take the above information on your records. Thanking You. For Archit Organosys Limited Kandarp Amin Chairman and Whole-time Director DIN: 00038972 Phone: +91-79-26873340/48925370 Unit: Survey No. 228/A, Paiki 7, Paiki 2, Village - Narmad, Bhavnagar-364313, Gujarat, India. E-MAIL: accounts@architorg.com | export@architorg.com | share@architorg.com | trading@architorg.com | Website: www.architorg.com ARCHIT ORGANOSYS MITE!) ANNUAL REPORT 2025-26 BOARD OF Shri Kandarp K. Amin - Chairman and Whole Time Director DIRECTORS: Smt. Archana Amin - Whole Time Director Shri Archit K. Amin - Whole Time Director Shri Shreeraj V. Desai - Independent Director Shri Nikul J. Patel - Independent Director Shri Bhavin G. Shah - Independent Director Shri Vatsal S. Vora - Independent Director Shri Anilkumar G. Patel - Chief Financial Officer KEY MANAGERIAL PERSONNEL: Shri Chirag Chouhan - Company Secretary and Compliance Officer BANKERS: Union Bank of India, Ellisbridge Branch, Ashram Road, Ahmedabad – 380006 STATUTORY AUDITOR: M/s. G. K. Choksi & Co., 12th Floor, North Tower, One 42, Billionaires St, off Ambli Road, Ashok Vatika, Ahmedabad - 380058, Gujarat. REGISTERED Registered office & Corporate Office OFFICE& UNITS: 9th Floor, Venus Benecia, Near Pakwan Restaurant, Bodakdev, S.G. Highway, Ahmedabad-380054 Manufacturing Unit Survey No. 228/A, Paiki 7, Paiki 2, Village-Narmad, Bhavnagar-364313 REGISTRAR MUFG Intime India Private Limited AND TRANSFER (Formerly known as Link Intime India Private Limited) AGENT Address: 1, ABC-1, 506 to 508, Amarnath Business Centre - 1 (ABC-1), Beside Gala Business Centre, Nr. St. Xavier's College Corner, Off C G Road, Ellisbridge Ahmedabad-380006, Gujarat, India. INDEX Sr. No. Particulars Page Nos. 1. Directors’ Report 01 2. Management Discussion and Analysis Report 07 3. Corporate Governance Report 09 4. Independent Auditors’ Report 35 5. Balance Sheet 55 6. Statement of Profit and Loss 56 7. Cash Flow Statement 57 8. Notes Forming Part of Accounts 58 Annual Report 2025-26 DIRECTOR’S REPORT THE MEMBERS, Your Directors have pleasure in presenting the 33rd Directors’ Report together with the Audited Financial Statement for the year ended on 31st March, 2026. 1. Financial Results: [Amount in Lacs] The operating results of the Company for the year ended on 31st March, 2026 are briefly indicated below: PARTICILARS 2025-26 2024-25 Total Income 14,383.71 12,869.20 Operating Cost including Depreciation 13,055.64 11,857.33 Financial Expenses 228.82 257.98 Total Expenses 13,284.46 12,115.31 Profit before Taxation and Exceptional Item 1,099.25 753.89 Exceptional Item 0.00 0.00 Profit before Taxation 1,099.25 753.89 Provision for taxation - For Current Tax 174.33 104.80 Provision for taxation - For Deferred Tax 111.16 148.78 Tax in respect of earlier years 10.55 (4.82) Profit after Taxation 803.21 505.11 DIVIDEND: The Board of Director have recommended a Dividend of Re. 1 (Rupee One Only) per equity share (@10 %) of Rs. 10/- (Rupees Ten Only) each, for the F.Y. 2025-26, subject to approval of members at the ensuing 33rd Annual General Meeting (AGM) of the Company. TRANSFER TO RESERVES: The Company has not transferred any amount to reserves during the year under review. STATE OF THE AFFAIRS OF THE COMPANY & FUTURE PROSPECTS: Total revenue from Operations of the Company for fiscal year 2026 stood at Rs. 14,383.71 Lakhs as compared to Rs. 12,869.20 Lakhs for fiscal year 2025, showing an increment of 11.77%; however, the Company was able to continue earning profit before tax by reaching profits of Rs.1,099.25 Lakhs compared to Rs. 753.89 Lakhs in the previous financial year. Further the Company is confident to have better future performance. MATERIAL CHANGES AND COMMITMENTS, IF ANY AFFECTING THE FINANCIAL POSITION OF THE COMPANY FROM THE CONCLUSION OF THE FINANCIAL YEAR TILL THE END OF THIS REPORT: There has been no other material changes and commitments, which affect the financial position of the Company which have occurred between the end of the financial year of the Company and the date of this report. CONSERVATION OF ENERGY, TECHNOLOGY ABSORPTION, FOREIGN EXCHANGE EARNINGS AND OUTGO: The information pertaining to conservation of Energy, Technology Absorption, Foreign Exchange Earnings and Outgo as required under Section 134 (3)(m) of the Companies Act, 2013 read with Rule 8(3) of the Companies (Accounts) Rules, 2014 is furnished in Annexure A which is attached to this report. MANAGEMENT DISCUSSIONS AND ANALYSIS REPORT: A report on Management Discussion and Analysis (“MDA”) is annexed to this report as Annexure B, inter-alia deals adequately with the operations and also current and future outlook of the Company. SHARE CAPITAL The paid-up Equity Share Capital as at 31st March, 2026 stood at Rs. 20,52,07,230/- consisting of 2,05,20,723 equity shares of Rs. 10/- each. ARCHIT ORGANOSYS LIMITED 01 ARCHIT ORGANOSYS LIMITED During the year under review, the Company has not: Company Secretary and Compliance Officer of the Company w.e.f. 1st August, • Issued any shares with differential voting rights 2025. • Granted any stock options 5. Re-appoint Shri Kandarp K. Amin (DIN: • Issued any sweat equity. 00038972) as the Chairman and Whole Time Director of the company for a period of None of the Directors of the Company held any instruments 3 years with effect from 1st April, 2026. convertible into equity shares of the Company as on 31st 6. Re-appoint Smt. Archana K. Amin (DIN: March, 2026. 00038985) as a Whole Time Director of the company for a period of 3 y [Showing first 8,000 characters — download PDF for full document]